Kelly Anderson - 07 Nov 2022 Form 4 Insider Report for Tharimmune, Inc. (THAR)

Role
Director
Signature
/s/ Randy Milby as Attorney-In-Fact for Kelly Anderson
Issuer symbol
THAR
Transactions as of
07 Nov 2022
Net transactions value
$0
Form type
4
Filing time
09 Nov 2023, 19:51:06 UTC
Previous filing
21 Jan 2022
Next filing
07 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THAR Options (right to buy) Award $0 +50,000 $0.000000 50,000 07 Nov 2023 Common stock 50,000 $0.1577 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 7, 2023, the Reporting Person was granted options ("Options") to purchase up to 50,000 shares of the Registrant's common stock pursuant to the Registrant's 2023 Omnibus Equity Incentive Plan. The Options vest in 12 equal monthly installments with the first installment vesting on the date of grant.